Genetic testing in patients with hypertrophic cardiomyopathy

Vnitrni Lekarstvi
|January 8, 2020
PubMed

Insights

Hypertrophic cardiomyopathy (HCM), a common inherited heart condition, has a complex genetic basis. Next Generation Sequencing (NGS) offers a faster, cost-effective way to identify genetic variants, aiding clinical management and future disease disruption.

Area of Science:

  • Cardiovascular Genetics
  • Genomic Medicine
  • Molecular Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac condition affecting up to 1 in 200 individuals.
  • HCM is typically autosomal dominant, linked to sarcomeric protein gene variants, but over 2,000 mutations across 27 genes are associated with the disease.
  • Conventional genetic analysis methods are time-consuming and costly due to genetic and allelic heterogeneity.

Purpose of the Study:

  • To highlight the complexity of hypertrophic cardiomyopathy genetics.
  • To introduce Next Generation Sequencing (NGS) as an efficient diagnostic tool for HCM.
  • To discuss the challenges and benefits of genetic variant interpretation in HCM.

Main Methods:

  • Utilized Next Generation Sequencing (NGS) for rapid, broad-scale genomic analysis of HCM-associated genes.
  • Discussed the challenges in interpreting numerous genetic variants of uncertain significance identified through large-scale screening.
  • Reviewed the role of clinical scoring systems in predicting genetic testing yield.

Main Results:

  • NGS enables analysis of numerous genes or whole genomes cost-effectively and accurately.
  • Genetic screening yields vary (20-40%), necessitating careful interpretation of identified variants.
  • Genetic testing facilitates mutation-specific family testing and clinical management.

Conclusions:

  • Identifying the genetic basis of HCM is crucial for understanding disease mechanisms.
  • Genetic insights into HCM offer opportunities for developing future therapeutic strategies.
  • NGS-based genetic testing is a valuable tool for HCM diagnosis, management, and research.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
311
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
260
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
255
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
388
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
204
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
168